When a big company takes over a little company, they pick out the bits that they think fit what they want, and leave the rest, said Michael Parnham, who was a senior scientific adviser at PLIVA at the time of the acquisition by GSK
& Fowler, A
This pattern has largely been reproduced in many, although not all, studies in non-human primates using different SHIVs, different nAbs and different challenge routes 12
The 60-80% absorption rate means more peptide reaches systemic circulation, potentially requiring lower total doses despite higher upfront costs
And it does different things in different tissues, but again, increases ATP production for energy
Similarly, Thymosin Beta-4 (Thymosin Beta-4) has been documented in initial research settings without serious adverse event reports